Background and Objectives: To ascertain the safety of repeat apheresis donation, hematological and biochemical tests were performed on 511 donors with a donation rate of over 6 times per year for a period of 12–19 months. Materials and Methods: Repeat donors who had apheresis more than 6 times in the previous year were chosen. Data for the repeat donors at the start of the experiments were compared with those at the end of the study. Blood samples were taken prior to donation. Serum protein, albumin, immunoglobulin G, A, and M, serum ferritin levels were determined by biochemical tests. Results: When compared to prospective donors of 400 ml, WBC, lymphocytes, and serum ferritin levels were lower in a roughly frequency–dependent manner in female and male donor groups at the beginning of the study. All the data for the male group remained almost constant with increasing frequency of apheresis donation. However, in the female group, ferritin levels significantly decreased with over 21 donations. Conclusions: The present data showed that the serum ferritin level of the female donors decreased the most with increasing frequency of apheresis donation. The cumulative RBC left in the collecting chamber and for the laboratory test is discussed in relation to a possible cause of iron deficiency in frequent apheresis donors.

Glowitz RJ, Slichter SJ: Frequent multiunit plateletpheresis from single donors: Effects on donor’s blood and the platelet yield. Transfusion 1979;20:199–205.
Rock G, Tittley P, Sternbach M, Buskard N, Schroeder M: Repeat plateletpheresis: The effects on the donor and the yield. Vox Sang 1992;63:102–106.
Matsui Y, Martin–Alosco S, Doenges E, Christenson L, Shapiro HM, Yunis EJ, Page PL: Effects of frequent and sustained plateletapheresis on peripheral blood mononuclear cell populations and lymphocyte functions of normal volunteer donors. Transfusion 1986;26: 446–452.
Paglieroni TG, Holland PV: Effects of serial plasmapheresis on serum IgA levels in IgA–deficient blood donors with IgA–suppressor T cells. Transfusion 1992;32:139–144.
Lewis SL, Kutvirt SG, Bonner PN, Simon TL: Plasma proteins and lymphocyte phenotypes in long–term plasma donors. Transfusion 1994; 34:578–585.
Friedman BA, Schork MA, Mocniak JL, Oberman HA: Short–term and long–term effects of plasmapheresis on serum proteins and immunoglobulins. Transfusion 1975;15:467–472.
Hollan SR: How much plasma, relative to his body weight, can a donor give over a certain period without a continuous deviation of his plasma protein metabolism in the direction of plasma protein deficiency? Vox Sang 1984;47: 438–439.
Nakano S, Imai M, Koganemaru T, Hara K, Ueda N, Tsutsumi Y, Ooyama M, Irita Y, Kiyokawa H, Maeda Y: Residual blood components in apheresis chamber after completion of plateletpheresis. (Japanese with English abstract and tables) Jpn Transfus Med 1995;41: 612–616.
Jacobs A, Miller F, Worwood M, Beamish MR, Wardrop CA: Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J 1972;28:206–208.
Clement AF, James DC, Robert FL, Maria C: Effect of blood donation on iron stores as evaluated by serum ferritin. Blood 1977;50:441– 447.
Expert Scientific Working Group: Summary of a report on assessment of the iron nutritional status of the United States population. Am J Clin Nutr 1985;42:1318–1330.
Strauss RG: Effects on donors of repeated leukocyte losses during plateletpheresis. J Clin Apheresis 1994;9:130–134.
Milman N, Sondenergaard M: Iron stores in male blood donors evaluated by serum ferritin. Transfusion 1984;24:464–468.
Standards for Blood Banks and Transfusion Services AABB, ed 17. 1996, Bethesda, pp 28–29.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.